Altoida, Inc.

Altoida, Inc.

Private
Washington D.C.Healthcare & Life Scienceshttps://altoida.com

Last Round

Series A

Extension

Mar 30, 2022

Total Funding Raised

$21.97M

Company Overview

Altoida, Inc. is a healthcare technology company that provides a precision neurology platform using AI and augmented reality to assess cognitive function and aid in the early detection of neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Medical Devices, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

digital biomarkerscognitive assessmentprecision neurologyAlzheimer's detectionbrain health assessmentsoftware-as-a-medical-deviceSaMDneurotechclinical trial technologyAR diagnosticsAI diagnosticsmild cognitive impairmentMCI detectioncognitive testingFDA Breakthrough Devicebrain checkup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Altoida, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Altoida, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 30, 2022
GrantSep 9, 2021
Series AJul 12, 2021
Series A ExtensionMay 4, 2020
Series AMay 31, 2019
Seed
Dec 30, 2016

Altoida, Inc. Investors

Notable investors and investment history

InvestorRounds
Grey Sky Venture PartnersSeries A
M VenturesSeries A Extension, Series A
VI PartnersSeries A Extension
Fyrfly Venture PartnersSeries A
b2ventureSeries A Extension
Alpana VenturesSeries A Extension, Series A
Whitecap Venture PartnersSeries A Extension

Altoida, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Altoida, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Altoida, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWashington D.C.
Employee Range28
Year Founded2016
Last FundingMar 30, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.